Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-17

Clinical Trial Update: Cabozantinib With Radiation Therapy for the Treatment of Sarcomas of the Extremities [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating cabozantinib with radiation therapy for soft tissue sarcoma of the trunk and extremities was terminated, with results posted on 2025-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cabozantinib (cabozantinib)

Snippet

Sponsor: University of Washington | Conditions: Sarcoma of the Extremity, Stage I Soft Tissue Sarcoma of the Trunk and Extremities | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-07-17